CNTY-101 is under clinical development by Century Therapeutics and currently in Phase I for Lupus Nephritis. According to GlobalData, Phase I drugs for Lupus Nephritis have an 84% phase transition ...

Zanubrutinib is under clinical development by BeiGene and currently in Phase II for Lupus Nephritis. According to GlobalData, Phase II drugs for Lupus Nephritis have a 50% phase transition success ...

Atherosclerosis progression was more than twice as common in younger people with systemic lupus erythematosus (SLE) than in ...

If reading about these atrocities churns your stomach, reflect on what is going on before our eyes these very days ...

A new study explored the potential of IncRNA CASC2 and miR-155 levels as non-invasive diagnostic biomarkers for systemic lupus erythematosus (SLE) and lupus nephritis (LN). Previous studies have found ...

Piper Sandler lowered the firm’s price target on Century Therapeutics (IPSC) to $4 from $12 and keeps an Overweight rating on the shares.

Now, scientists at Stanford University have found that a faulty genetic molecule could be responsible for the immune system misidentifying healthy tissue as a threat. The breakthrough study, published ...

A couple from a small town outside Peoria celebrated their first Christmas with their new baby after a scary cancer diagnosis ...

An analysis of 2024 Google search data revealed the top health questions asked by Americans. A registered nurse provides ...

Legendary R&B band, The O’Jays lead singer Eddie Levert has lost his youngest daughter, Ryan Levert, at age 22.

Eddie Levert, the legendary singer of the O’Jays, is reportedly mourning the loss of his youngest daughter, Ryan Levert.